With markets bouncing between optimism and anxiety thanks to interest-rate uncertainty and questions around the strength of the global tech rally, it is easy to forget one simple truth.
That is that long-term investors don’t need perfect conditions, they just need great businesses.
And right now, the ASX is home to a handful of high-quality growth stars that continue to deliver through cycles, build global scale, and strengthen their competitive advantages year after year.
These aren’t speculative punts, they are proven, profitable, long-run compounders with enormous addressable markets.
If I had to pick three ASX growth shares to back for the next five years, these would be at the top of my list.
Life360 Inc. (ASX: 360)
Life360 has quietly become one of Australia’s most impressive global tech success stories. Its family safety app now reaches 91.6 million monthly active users, up 19% year on year, and its subscriber base continues to surge, with 2.7 million paying circles after adding a record 170,000 in the last quarter.
The company’s revenue momentum is equally impressive. In the third quarter of FY 2025, Life360 delivered US$124.5 million in total revenue. This was up 34% year on year, with subscription revenue rising at the same pace.
In addition, its adjusted EBITDA jumped 174% to US$24.5 million, while operating cash flow surged 319% to US$26.4 million. Annualised monthly revenue last stood at US$446.7 million, reflecting the growing value of its subscriber ecosystem.
With a massive global addressable market, new product opportunities, and US$457.2 million in cash, Life360 looks exceptionally well placed for another five years of strong, scalable growth.
Pro Medicus Ltd (ASX: PME)
Another ASX growth share that I would buy is Pro Medicus. Its Visage imaging platform has become the go-to choice for major hospitals and radiology groups across the United States, which is the most lucrative healthcare market in the world. Every new contract improves long-term revenue visibility thanks to multi-year, multi-million-dollar deals that scale with usage.
The company’s margins are among the highest on the ASX, and its capital-light model means much of its revenue flows straight through to profit and cash.
With radiology workloads rising, radiologist shortages, and hospitals under pressure to do more with less, Pro Medicus is positioned at the heart of a long-term digital transformation.
WiseTech Global Ltd (ASX: WTC)
Finally, WiseTech is a third ASX growth share I would buy. Its CargoWise platform is now used by many of the world’s largest freight forwarders and logistics groups, managing everything from international shipping to customs processes.
As supply chains become more complex and companies push for efficiency, automation, and transparency, WiseTech’s role becomes increasingly essential.
The company continues to expand globally through both organic growth and strategic acquisitions, adding new capabilities in areas such as customs software, compliance, and logistics optimisation. Its recurring revenue model, sticky customer relationships, and high margins give it the kind of long-term compounding profile growth investors love.
Over a five-year horizon, I believe WiseTech will be significantly larger than it is today.
The post 3 ASX growth stars I’d back for the next five years appeared first on The Motley Fool Australia.
Should you invest $1,000 in Life360 right now?
Before you buy Life360 shares, consider this:
Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Life360 wasn’t one of them.
The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
And right now, Scott thinks there are 5 stocks that may be better buys…
* Returns as of 18 November 2025
.custom-cta-button p {
margin-bottom: 0 !important;
}
More reading
- 5 things to watch on the ASX 200 on Monday
- What I’d buy first if the ASX share market fell 30%
- My plan of attack for the next share market crash
- Here are the top 10 ASX 200 shares today
- Why Gentrack, Kogan, Webjet, and WiseTech shares are pushing higher today
Motley Fool contributor James Mickleboro has positions in Life360, Pro Medicus, and WiseTech Global. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Life360 and WiseTech Global. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has positions in and has recommended Life360 and WiseTech Global. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
Leave a Reply